Long-acting combination of cabotegravir plus rilpivirine: a picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort.

Adriana Cervo,Antonio Russo,Domenico Di Carlo,Andrea De Vito,Lavinia Fabeni,Stefano D'Anna,Leonardo Duca,Agnese Colpani, Marco Fois,Beatrice Zauli, Giulia Mancarella,Anna Carraro,Antonia Bezenchek,Alessandro Cozzi-Lepri,Maria Mercedes Santoro

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY（2023）

引用 1|浏览18

暂无评分

摘要

Less than half of virologically suppressed PLWH in the ARCA cohort were potentially eligible for CAB+RPV. They seem to be "less complicated" with shorter exposure to ART and preferably already on NNRTIs.

查看译文

关键词

cabotegravir,rilpivirine,long-acting,hiv-positive

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要